This pathology discussion focuses on a challenging case exhibiting a palisaded granulomatous growth pattern, initially mimicking benign entities like Deep Granuloma Annulare (DGA) or Rheumatoid Nodule. However, the presence of large, atypical epithelioid cells surrounding the central amorphous/pale area raises strong suspicion for Epithelioid Sarcoma (ES). The video emphasizes that ES is a rare, high-mortality tumor that often presents subtly on the distal extremities of young patients, leading to frequent diagnostic pitfalls and delays. Definitive diagnosis relies heavily on immunohistochemistry (IHC), characterized by co-expression of epithelial markers (Keratin, EMA) and, most critically, the nuclear loss of INI1 (SMARK B1), which is absent in over 90% of cases.
Epithelioid Sarcoma: A Diagnostic Pitfall
0:07 Differential Diagnosis: The specimen presents with a "palisated granulomitus dermatitis" pattern, resembling Deep Granuloma Annulare (DGA) or Rheumatoid Nodule.
0:45 Key Morphological Features: Suspicion shifts to Epithelioid Sarcoma (ES) due to the presence of large, atypical epithelioid cells at the periphery of the amorphous/pale center, featuring large nuclei and hyperlasia. The presenter notes ES is an entity they are constantly afraid of missing due to its subtlety.
1:12 Crucial IHC Marker: The diagnostic standard for ES is the loss of nuclear expression of INI1 (SMARK B1), which is seen in over 90% of cases. Normal surrounding cells should express this protein.
1:36 Classic Staining Profile: Historically, ES was recognized for being positive for both Keratin and Vimentin, and commonly positive for CD34 (02:01), though CD34 is a non-specific marker.
2:50 Technical Challenges with INI1: The presenter notes that INI1 can be technically difficult and unreliable, recommending the use of Pan-keratin and EMA (04:10) as initial screening stains due to their reliability, followed by INI1 confirmation when suspicion is high.
3:31 Cytomorphology Tip: ES cells are typically larger and more atypical than those seen in GA or rheumatoid nodules, often displaying pale, vacuolated chromatin.
4:46 Distinction from Benign Mimics: Unlike GA or Rheumatoid Nodules, which are histiocytic processes, ES frequently contains central necrotic tumor cells (ghosted out tumor cells) within the degenerated collagen/mucin background.
5:38 Clinical Presentation Pitfall: ES typically affects young adults or children and presents as a non-specific nodule on the distal extremities (hands, feet, wrist, ankle). It frequently ulcerates and can be mistaken for non-healing infections or benign ulcers, leading to delayed diagnosis.
7:01 Prognosis and Recurrence: ES is a "terrible tumor" that is difficult to diagnose and has a poor prognosis (approximately 50% long-term mortality). It has a high tendency to recur locally (satellite lesions, in-transit metastases) and metastasize to regional lymph nodes.
7:56 Specimen Context: Evidence of suture granuloma and scar tissue confirms the specimen is likely a complete excision following a prior biopsy, illustrating the surgical treatment required for this malignancy.